Skip to main content

Table 2 Physiological parameters and laboratories of patients during the first 24-h hospital admission, stratified by the different advance ventilatory supports

From: Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Measure

All

HFNC

NIV

IMV

p value

Value

n

Value

n

Value

n

Value

n

Physiological parameters on admission, median (IQR)

Diastolic blood pressure (mmHg)

74.0 (65.0–83.0)

64,667

74.0 (65.0–83.0)

27,806

75.0 (66.0–83.0)

23,713

73.0 (64.0–82.0)

13,148

 < 0.001

Heart rate (beats/min)

92.0 (80.0–106.0)

64,563

91.0 (80.0–105.0)

27,564

94.0 (82.0–107.0)

23,756

93.0 (81.0–108.0)

13,243

 < 0.001

Respiratory rate (breaths/min)

24.0 (20.0–28.0)

63,891

22.0 (20.0–28.0)

27,631

24.0 (20.0–30.0)

23,439

24.0 (20.0–28.0)

12,821

 < 0.001

Systolic blood pressure (mmHg)

129.0 (115.0–144.0)

64,745

129.0 (114.0–144.0)

27,828

130.0 (116.0–145.0)

23,740

129.0 (113.0–142.0)

13,177

 < 0.001

Temperature (C)

37.2 (36.7–38.1)

64,519

37.2 (36.6–38.1)

27,763

37.3 (36.7–38.2)

23,685

37.0 (36.7–37.8)

13,071

 < 0.001

Laboratory during the first 24 h, median (IQR)

Alanine aminotransferase (U/L)

32.0 (21.0–53.0)

28,901

29.0 (19.0–48.0)

13,612

34.0 (22.0–55.0)

10,956

38.0 (25.0–62.6)

4333

 < 0.001

Aspartate aminotransferase (U/L)

50.0 (33.0–77.0)

6614

47.0 (31.0–73.0)

2413

51.0 (34.0–78.0)

2085

51.0 (34.0–81.0)

2116

 < 0.001

Base excess (mmol/L)

0.0 (− 2.8–2.5)

7017

0.5 (− 2.1–2.9)

2542

0.3 (− 2.2–2.6)

2379

 − 1.0 (− 4.0–1.9)

2096

 < 0.001

Bicarbonate (mEq/L)

23.0 (20.4–25.8)

9601

23.5 (20.9–25.9)

2254

23.1 (20.5–26.0)

2536

23.0 (20.0–25.7)

4811

 < 0.001

Bilirubin (umol/L)

10.0 (7.0–14.0)

29,034

9.0 (7.0–14.0)

13,705

10.0 (7.0–14.0)

11,029

9.0 (6.0–15.0)

4300

 < 0.001

C reactive protein (mg/L)

106.0 (53.0–179.0)

34,518

94.4 (48.0–161.55)

16,762

118.0 (63.0–191.0)

13,899

118.5 (45.63–213.7)

3857

 < 0.001

Creatine kinase (U/L)

163.0 (76.0–427.75)

4702

151.5 (67.75–409.0)

1880

164.0 (80.0–431.0)

1557

179.0 (83.0–450.0)

1265

0.001

Creatinine (umol/L)

87.0 (68.95–120.0)

42,151

87.0 (69.0–120.0)

17,420

87.0 (69.0–116.0)

14,859

87.52 (67.19–126.41)

9872

0.20

D-Dimer (mg/L)

2.76 (0.9–375.0)

1395

1.54 (0.75–9.82)

357

6.94 (0.89–607.0)

303

3.68 (1.02–453.0)

735

 < 0.001

Ferritin (ug/L)

810.0 (384.0–1523.0)

6244

735.0 (326.0–1425.7)

2542

838.0 (411.92–1535.5)

2460

942.0 (447.0–1672.75)

1242

 < 0.001

Glucose (mmol/L)

7.55 (6.2–10.4)

33,299

7.0 (5.9–9.3)

12,720

7.6 (6.3–10.5)

12,543

8.49 (6.83–11.84)

8036

 < 0.001

Haematocrit (%)

39.0 (34.6–42.3)

11,810

39.7 (35.1–43.0)

2389

39.0 (35.0–42.8)

3064

38.6 (34.0–42.0)

6357

 < 0.001

Haemoglobin (g/L)

133.0 (117.0–146.0)

50,242

133.0 (118.0–146.0)

20,731

135.0 (121.0–148.0)

19,009

127.0 (109.0–142.0)

10,502

 < 0.001

Interleukin 6 (ng/L)

67.6 (23.0–169.0)

433

43.51 (13.33–89.3)

107

49.4 (21.48–129.5)

128

131.3 (31.1–313.0)

198

 < 0.001

Lactate dehydrogenase (U/L)

487.0 (349.0–684.0)

7570

445.5 (328.0–621.5)

2966

532.0 (374.0–741.0)

2837

496.0 (353.0–708.5)

1767

 < 0.001

Lactic acid (mmol/L)

1.5 (1.1–2.1)

21,382

1.4 (1.05–2.0)

9154

1.5 (1.1–2.04)

8553

1.55 (1.1–2.3)

3675

 < 0.001

Leukocytes (109/L)

8.07 (5.7–12.0)

50,673

7.4 (5.4–10.5)

21,036

7.8 (5.6–11.3)

19,043

10.77 (7.0–18.2)

10,594

 < 0.001

Lymphocytes (109/L)

0.8 (0.58–1.2)

36,068

0.81 (0.59–1.2)

18,019

0.8 (0.58–1.11)

14,760

0.82 (0.55–1.3)

3289

 < 0.001

Lymphocytes/leukocytes (%)

9.7 (5.35–15.65)

879

11.0 (6.8–16.1)

357

8.95 (5.0–16.58)

130

8.6 (4.57–15.0)

392

 < 0.001

Neutrophils (109/L)

5.8 (4.0–8.63)

35,963

5.6 (3.87–8.31)

18,020

5.8 (4.0–8.43)

14,719

7.5 (4.7–11.5)

3224

 < 0.001

Neutrophils/leukocytes (%)

82.0 (72.9–88.0)

697

81.9 (74.4–87.3)

293

80.4 (70.0–87.7)

101

83.2 (73.2–88.95)

303

0.26

Platelets (109/L)

199.0 (140.0–265.0)

50,263

207.0 (157.0–271.0)

20,811

202.0 (148.0–265.0)

18,903

162.0 (0.3–249.0)

10,549

 < 0.001

Potassium (mmol/L)

4.1 (3.8–4.5)

35,901

4.1 (3.74–4.5)

14,512

4.1 (3.8–4.5)

12,433

4.2 (3.8–4.6)

8956

 < 0.001

Procalcitonin (ug/L)

0.24 (0.12–0.7)

6234

0.2 (0.1–0.51)

2191

0.24 (0.12–0.62)

2839

0.4 (0.15–1.38)

1204

 < 0.001

Prothrombin intl. (ratio)

1.1 (1.02–1.3)

2728

1.09 (1.0–1.2)

611

1.1 (1.03–1.3)

604

1.14 (1.04–1.3)

1513

 < 0.001

Prothrombin time (s)

13.0 (11.3–14.5)

25,413

12.8 (11.1–14.4)

11,834

13.0 (11.4–14.5)

10,400

13.3 (11.8–14.8)

3179

 < 0.001

Sodium (mmol/L)

136.0 (133.0–140.0)

38,268

137.0 (134.0–140.0)

15,894

136.0 (133.0–139.0)

13,253

137.0 (133.0–141.0)

9121

 < 0.001

Troponin I (ug/L)

0.07 (0.02–6.9)

1437

0.03 (0.01–0.25)

398

0.08 (0.02–10.3)

257

0.13 (0.02–10.0)

782

 < 0.001

Urea nitrogen (mmol/L)

7.7 (5.1–12.85)

46,588

7.1 (4.9–11.5)

19,388

7.3 (5.0–11.6)

17,614

10.35 (6.2–18.56)

9586

 < 0.001

  1. Bold values indicate statistical significance
  2. HFNC high-flow nasal cannula, NIV non-invasive mechanical ventilation, IMV invasive mechanical ventilation, IQR interquartile range, PTT partial thromboplastin time